Form 4: Bausch Health CEO Thomas Appio Receives Restricted Share Units

Bausch Health Companies Inc. CEO Thomas Appio was granted 635,425 restricted share units (RSUs) on February 26, 2025, according to a recent SEC filing.

Summary

• Thomas Appio, CEO of Bausch Health Companies Inc., received 635,425 restricted share units (RSUs) on February 26, 2025.
• These RSUs will vest in three equal installments on the first three anniversaries of the grant date, contingent upon Appio's continued service with the company.
• Upon vesting, the RSUs will be settled in common shares of Bausch Health Companies Inc.
• Following the reported transaction, Appio beneficially owns 1,990,098 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, indicating confidence in the CEO's continued service and alignment with shareholder interests.

Positives

• The vesting schedule of the RSUs incentivizes the CEO to remain with the company for the long term.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Grants of restricted stock units are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Stakeholder Impact

• The RSU grant aligns the CEO's interests with those of shareholders, potentially driving long-term value creation.

Key Dates